A Review on the Safety of Using JAK Inhibitors in Dermatology: Clinical and Laboratory Monitoring

Janus kinase (JAK) inhibitors are disease-modifying agents with efficacy in treating a spectrum of burdensome dermatologic conditions. The US Food and Drug Administration (FDA) recently placed a black box warning on this class of medications due to safety concerns based on data from studies investig...

Descripción completa

Detalles Bibliográficos
Autores principales: Samuel, Christeen, Cornman, Hannah, Kambala, Anusha, Kwatra, Shawn G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9930707/
https://www.ncbi.nlm.nih.gov/pubmed/36790724
http://dx.doi.org/10.1007/s13555-023-00892-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9930707/
https://www.ncbi.nlm.nih.gov/pubmed/36790724
http://dx.doi.org/10.1007/s13555-023-00892-5

Ejemplares similares